NCT04691791 (ITACA) is a clinical trial in Congenital Coronary Artery Abnormality, sponsored by ITAB - Institute for Advanced Biomedical Technologies.

Who is sponsoring NCT04691791?

NCT04691791 is sponsored by ITAB - Institute for Advanced Biomedical Technologies.

What condition does NCT04691791 study?

NCT04691791 studies Congenital Coronary Artery Abnormality.

Is NCT04691791 still recruiting?

NCT04691791 is currently completed. Last updated 3 March 2023.

Last reviewed 2023-03-03 · How we verify

NCT04691791: ITACA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Italian Registry of Cardiovascular Magnetic Resonance on Congenital Anomalies of the Coronary Arteries (ITACA-Registry)

Completed Last updated 3 March 2023

What this trial tests

trial in Congenital Coronary Artery Abnormality in 100 participants. Completed in 31 October 2022.

Timeline

1 September 2019

Primary endpoint
30 September 2022

31 October 2022

Quick facts

Lead sponsor	ITAB - Institute for Advanced Biomedical Technologies
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 September 2019
Primary completion	30 September 2022
Estimated completion	31 October 2022
Sites	1 location across Italy

Conditions studied

Congenital Coronary Artery Abnormality — all drugs for Congenital Coronary Artery Abnormality →

Sponsor

ITAB - Institute for Advanced Biomedical Technologies

Who can join

Eligibility, any sex, with Congenital Coronary Artery Abnormality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Italian registry of coronary artery abnormalities diagnosed utilizing cardiac magnetic resonance imaging.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other ITAB - Institute for Advanced Biomedical Technologies trials

Trials by the same sponsor.

NCT05824221 — Effect of rTMS on Neurotrophines Levels in CUD · NA · unknown
NCT05798143 — Translational Biomarkers in Accelerated Neuromodulation for Treatment-resistant Depression · NA · recruiting
NCT04897295 — Neurobiological Effects of Transcranial Direct Current Stimulation Treatment in Alcohol Use Disorder · NA · not yet recruiting
NCT05016479 — Accelerated rTMS in Gambling Disorder: a Multicentric, Randomized, Sham-controlled Trial · NA · unknown
NCT03336879 — Repetitive Transcranial Magnetic Stimulation in Gambling Disorder · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04691791 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ITAB - Institute for Advanced Biomedical Technologies
Last refreshed: 3 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04691791.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing